Asthma vs. COPD: Understanding the Differences, Overlap, and Treatment Options

Asthma and chronic obstructive pulmonary disease (COPD) are the two most common chronic respiratory conditions, together affecting over 300 million people worldwide. Both cause shortness of breath, coughing, and wheezing -- which is why patients frequently ask, "Do I have asthma or COPD?"

While the symptoms may feel similar, these are fundamentally different diseases with distinct causes, progression patterns, and treatment strategies. Getting the diagnosis right matters because the wrong treatment approach can leave symptoms uncontrolled and accelerate lung function decline.

What Is Asthma?

Asthma is a chronic inflammatory airway disease characterized by variable airflow obstruction and bronchial hyperresponsiveness. The hallmark of asthma is reversibility -- airways narrow during episodes but return to normal baseline between flare-ups.

Key features of asthma include:

• Onset: Most commonly begins in childhood, though adult-onset asthma is well recognized
• Inflammation type: Typically eosinophilic (allergic) or type 2 inflammation, though phenotypes vary
• Triggers: Allergens, exercise, cold air, respiratory infections, environmental irritants
• Lung function: Normal between episodes in well-controlled disease
• Smoking history: Not required -- many asthma patients have never smoked
• Family history: Strong genetic component, often associated with atopy (allergies, eczema, hay fever)

What Is COPD?

COPD is a progressive lung disease characterized by persistent airflow limitation that is not fully reversible. It encompasses two main conditions: chronic bronchitis (inflammation and narrowing of the bronchial tubes with excess mucus) and emphysema (destruction of the alveoli, the tiny air sacs where gas exchange occurs).

Key features of COPD include:

• Onset: Typically develops after age 40, often diagnosed in the 50s or 60s
• Inflammation type: Predominantly neutrophilic, with CD8+ T-cell involvement
• Primary cause: Long-term cigarette smoking (responsible for 80-90% of cases), though occupational exposures, biomass fuel smoke, and alpha-1 antitrypsin deficiency are also recognized causes
• Lung function: Progressive decline even with treatment; airflow limitation is persistent
• Symptoms: Chronic productive cough, progressive exertional dyspnea, frequent respiratory infections
• Family history: Less prominent genetic component (except alpha-1 antitrypsin deficiency)

Side-by-Side Comparison: Asthma vs. COPD

The following table summarizes the key clinical differences between the two conditions:

How Asthma and COPD Are Diagnosed

Accurate diagnosis requires a systematic approach combining clinical assessment with objective testing. At Advanced Asthma Clinic, Dr. Frank Hull uses comprehensive pulmonary function testing to distinguish between these conditions.

Spirometry with Bronchodilator Reversibility

Spirometry is the foundation of diagnosis for both conditions. The test measures how much air you can exhale forcefully (FVC) and how quickly you can exhale in the first second (FEV1). The ratio of FEV1/FVC below 0.70 indicates airflow obstruction.

The critical distinction comes from bronchodilator reversibility testing: after inhaling a short-acting bronchodilator such as albuterol, patients with asthma typically show a significant improvement in FEV1 (12% or more and at least 200 mL), while patients with COPD show minimal change. However, some COPD patients do show partial reversibility, which is why this test alone is not always definitive.

Additional Diagnostic Tests

• Fractional exhaled nitric oxide (FeNO): Elevated levels suggest eosinophilic airway inflammation, which is more characteristic of asthma
• Blood eosinophil count: Helps identify type 2 inflammation and guide biologic therapy selection
• Allergy testing: Skin prick or blood IgE testing; positive results support an asthma diagnosis, particularly allergic asthma
• Lung volumes and diffusion capacity (DLCO): Increased total lung capacity and reduced DLCO suggest emphysema (COPD)
• CT chest: Can reveal emphysematous changes, bronchial wall thickening, or air trapping
• Peak flow variability: Marked day-to-day or diurnal variability in peak expiratory flow supports asthma

Asthma-COPD Overlap (ACO)

Not every patient fits neatly into one category. An estimated 15-20% of patients with obstructive airway disease have features of both asthma and COPD -- a condition known as Asthma-COPD Overlap (ACO), previously called Asthma-COPD Overlap Syndrome (ACOS).

ACO is more common in certain populations:

• Long-standing asthma patients who smoke or have smoked
• COPD patients with a history of childhood asthma or atopy
• Patients with severe asthma who develop fixed airflow obstruction from airway remodeling
• Older adults where the clinical picture becomes less clear with age

Why ACO Matters

Patients with ACO tend to have worse outcomes than those with either condition alone:

• More frequent and severe exacerbations
• Faster decline in lung function
• Greater symptom burden and reduced quality of life
• Higher healthcare utilization (emergency visits, hospitalizations)
• Increased mortality compared to asthma or COPD alone

Recognizing ACO is critical because treatment differs from either condition in isolation. Patients with ACO generally benefit from inhaled corticosteroids (which are standard in asthma but used selectively in COPD), combined with long-acting bronchodilators used in COPD management.

Can Asthma Turn Into COPD?

This is one of the most common questions patients ask. Strictly speaking, asthma does not "become" COPD -- they are distinct diseases with different underlying mechanisms. However, there are important connections:

• Airway remodeling: Chronic, poorly controlled asthma can cause permanent structural changes in the airways -- thickening of the airway walls, subepithelial fibrosis, and smooth muscle hypertrophy. This remodeling can lead to fixed airflow obstruction that clinically resembles COPD.
• Smoking + asthma: People with asthma who smoke face a dramatically accelerated decline in lung function compared to non-smoking asthma patients. Smoking with asthma significantly increases the risk of developing COPD as a coexisting condition.
• Lung function trajectory: Some studies suggest that children with severe asthma who never achieve normal lung function may be on a trajectory toward fixed obstruction in adulthood, even without smoking.

The takeaway: maintaining good asthma control, avoiding tobacco exposure, and monitoring lung function regularly are essential strategies for preserving long-term lung health and reducing the risk of developing irreversible obstruction.

Treatment Differences: Asthma vs. COPD

While both conditions use inhalers and bronchodilators, the treatment philosophies differ significantly:

Asthma Treatment

• Foundation: Inhaled corticosteroids (ICS) are the cornerstone of asthma therapy, targeting the underlying eosinophilic inflammation
• Add-on therapies: Long-acting beta-agonists (LABA), leukotriene modifiers, tiotropium
• Severe asthma: Biologic therapies targeting specific inflammatory pathways (IgE, IL-5, IL-4/IL-13, TSLP)
• Rescue: Short-acting bronchodilators for acute symptoms
• Goal: Complete symptom control, normal lung function, prevention of exacerbations
• Learn more about asthma medications and strategies for reducing steroid dependence

COPD Treatment

• Foundation: Long-acting bronchodilators (LABA and/or LAMA) are the mainstay
• ICS role: Added only for patients with frequent exacerbations and/or elevated eosinophils -- not used universally as in asthma
• Additional therapies: Pulmonary rehabilitation, supplemental oxygen (if hypoxemic), phosphodiesterase-4 inhibitors
• Smoking cessation: The single most important intervention to slow disease progression
• Goal: Symptom reduction, slowing disease progression, reducing exacerbations, improving exercise capacity

ACO Treatment Approach

Patients with overlap features generally require a combined approach: ICS (to address the asthma component) plus long-acting bronchodilators (LABA and/or LAMA for the COPD component). Biologic therapies may be appropriate for ACO patients with elevated eosinophils or other type 2 biomarkers. Treatment must be individualized based on the dominant features and biomarker profile.

When to See a Pulmonologist

If you experience persistent respiratory symptoms -- especially shortness of breath, chronic cough, or wheezing -- it is important to get an accurate diagnosis rather than assuming which condition you have. You should consult a pulmonologist if:

• Your symptoms are not responding to current treatment
• You have been told you have asthma but also have a significant smoking history
• Your breathing is getting progressively worse despite medication
• You experience frequent exacerbations or emergency department visits
• You are unsure whether you have asthma, COPD, or both
• You want comprehensive lung function testing to clarify your diagnosis

Clinical Trials for Asthma and COPD

Advanced Asthma Clinic is affiliated with Lung Research Florida, which conducts clinical trials investigating new therapies for both severe asthma and COPD. Clinical trials offer eligible patients access to cutting-edge treatments before they become widely available, often at no cost. If you are interested in participating, call 954-520-7296 ext. 1 or visit lungresearchflorida.com.

Expert Asthma and COPD Care in Plantation, FL

Dr. Frank Hull is a board-certified pulmonologist with over 20 years of experience in respiratory medicine and clinical research. At Advanced Asthma Clinic in Plantation, Florida, Dr. Hull provides comprehensive diagnostic evaluation and personalized treatment plans for patients with asthma, COPD, and asthma-COPD overlap. Using advanced pulmonary function testing, biomarker analysis, and the latest evidence-based therapies -- including biologic treatments for severe disease -- Dr. Hull helps patients achieve the best possible lung health outcomes.

If you are struggling with breathing problems and want an accurate diagnosis, contact Advanced Asthma Clinic at 954-522-7226 to schedule your evaluation. Financial assistance may be available through the Better Breathing Grant program.

This article is for educational purposes only and does not replace professional medical advice. Always consult your physician for diagnosis and treatment recommendations specific to your condition.